COVID-19 vaccine development: What lessons can we learn from TB?

At the time of writing, the SARS-CoV-2 virus has infected more than 49 million people causing more than 1.2 million deaths worldwide since its emergence from Wuhan, China in December 2019. Vaccine development against SARS-CoV-2 has drawn the global attention in order to stop the spread of the virus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Safar, Hussain A., Mustafa, Abu Salim, McHugh, Timothy D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702199/
https://www.ncbi.nlm.nih.gov/pubmed/33256750
http://dx.doi.org/10.1186/s12941-020-00402-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702199/
https://www.ncbi.nlm.nih.gov/pubmed/33256750
http://dx.doi.org/10.1186/s12941-020-00402-x

Ejemplares similares